Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Enbrel 50mg/1ml inj pre-filled MyClic pens
1001030D0BBAFAE
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | 3 |
|
Enbrel 25mg inj vials
1001030D0BBAAAA
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel 25mg/0.5ml inj pre-filled MyClic pens
1001030D0BBAHAG
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel 25mg/0.5ml solution for injection pre-filled syringes
1001030D0BBAEAD
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel 50mg inj vials
1001030D0BBABAB
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel 50mg/1ml solution for injection pre-filled syringes
1001030D0BBACAC
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel Paediatric 10mg inj vials
1001030D0BBAGAF
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel Paediatric 25mg inj vials
1001030D0BBADAA
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.